Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immucor -- Ignore unavailable to you. Want to Upgrade?

To: Mason Barge who wrote (166)	8/27/1998 6:11:00 AM
From: Thomas Kirwin	Respond to of 422

Worth Repeating Mason, I thought that this snip was worth repeating as it indicates sales of the ABS2000 as well as the ROSYS Plato have been brisk. Looking forward to seeing some official sales announcements. "Commenting further, Mr. Gallup stated, ''We are very pleased with our initial success with the ROSYS Plato and the ABS2000 (FDA cleared July 6, 1998). We expect installations to begin in early September and believe the associated revenue and earnings growth will ensure that our share repurchase efforts will add significant value for our shareholders." Regards, Tom

To: Mason Barge who wrote (166)	8/27/1998 7:05:00 AM
From: Thomas Kirwin	Read Replies (1) \| Respond to of 422

Stock Repurchase Program Analysis Mason, The recent stock repurchase news release confirms that Immucor has been intensifying their efforts in this area. As of May '98 Immucor's the 10-K stated "Through May 31, the Company repurchased approximately 103,000 shares of its common stock for $877,000 under the program." The recent news release dated August 26th reveals "To date 582,000 shares have been purchased under the 1997 program." Looks as though Immucor bought 479,000 shares in the last three months. The total shares purchased under the original program represents 7.18% of the outstanding shares. The above tells me that management really believes their stock is undervalued based on future internal earnings projections and potential. In fact, they just announced that the board of directors has authorized the company to repurchase up to an additional 800,000 shares of its common stock. I am impressed! Regards, Tom